Make scientific figures in minutes
Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software
Use Icons In The App
Try a synonym, or sign up to request an icon from the app.
Lymphocyte (neoplastic)
[{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cef/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cef/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cee/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cee/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2ced/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2ced/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cec/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cec/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2ceb/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2ceb/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cea/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cea/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2ce9/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2ce9/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2ce8/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2ce8/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2ce7/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2ce7/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2ce6/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2ce6/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2ce5/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2ce5/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2ce4/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2ce4/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2ce3/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2ce3/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2ce2/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2ce2/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2ce1/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2ce1/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2ce0/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2ce0/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cdf/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cdf/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cde/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cde/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cdd/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cdd/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cdc/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cdc/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cdb/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cdb/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cda/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cda/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cd9/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cd9/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cd8/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cd8/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cd7/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cd7/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cd6/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cd6/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cd5/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cd5/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cd4/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cd4/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cd3/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cd3/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cd2/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cd2/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cd1/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cd1/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cd0/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cd0/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2ccf/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2ccf/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cce/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cce/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2ccd/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2ccd/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2ccc/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2ccc/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2ccb/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2ccb/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cca/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cca/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cc9/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cc9/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cc8/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cc8/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cc7/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cc7/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cc6/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cc6/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cc5/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cc5/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cc4/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cc4/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cc3/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cc3/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cc2/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cc2/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cc1/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cc1/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cc0/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cc0/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cbf/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cbf/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cbe/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cbe/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cbd/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cbd/615b652bfbd68200297651cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/615c71322c69940029be2cbc/615b652bfbd68200297651cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/615c71322c69940029be2cbc/615b652bfbd68200297651cf.png"}]
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes
.png)
SIGN UP FREEKeywords
lymphotcyte,white blood cell,wbc,leukocyte,peripheral blood mononuclear cell,PBMC,neoplastic,pre-cancer,cancerous,neoplasia,neoplasm,malignant,irregular,tumor,tumour,abnormal,lymph,natural killer cell,nk cell,tcell,t cell,bcell,b cell,internalcellupdate-high-impact-21q3 ,lymphocyte
Image types
BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More
Related Categories
Join 1,500,000 other scientists on BioRender
Sign up for your free account and start creating scientific figures faster today
FAQs
What is BioRender?
Can I use this icon in a BioRender figure or scientific illustration?
